Synovus Financial Corp Rocket Pharmaceuticals, Inc. Transaction History

Synovus Financial Corp

$7.79 Billion
Q4 2024

A detailed history of Synovus Financial Corp transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Synovus Financial Corp holds 163,893 shares of RCKT stock, worth $1.72 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

163,893

Previous 95,504 71.61%

Holding current value

$1.72 Million

Previous $1.76 Million 16.85%

% of portfolio

0.03%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$11.35 - $18.82 $776,215 - $1.29 Million	68,389 Added 71.61%	163,893 $2.06 Million
Q3 2024 Nov 14, 2024	SELL	$17.6 - $25.88 $1.28 Million - $1.88 Million	-72,586 Reduced 43.18%	95,504 $1.76 Million
Q2 2024 Aug 13, 2024	BUY	$20.66 - $26.72 $1.75 Million - $2.26 Million	84,679 Added 101.52%	168,090 $3.62 Million
Q1 2024 May 14, 2024	SELL	$26.16 - $30.74 $33,223 - $39,039	-1,270 Reduced 1.5%	83,411 $2.25 Million
Q3 2023 Nov 13, 2023	BUY	$15.07 - $24.05 $55,743 - $88,960	3,699 Added 4.57%	84,681 $1.74 Million
Q2 2023 Aug 08, 2023	SELL	$16.59 - $23.6 $89,785 - $127,723	-5,412 Reduced 6.26%	80,982 $1.61 Million
Q1 2023 May 11, 2023	SELL	$15.79 - $22.6 $671,390 - $960,952	-42,520 Reduced 32.98%	86,394 $1.48 Million
Q4 2022 Feb 06, 2023	BUY	$15.5 - $22.76 $645,745 - $948,204	41,661 Added 47.75%	128,914 $2.52 Million
Q3 2022 Oct 27, 2022	SELL	$12.37 - $18.41 $5,046 - $7,511	-408 Reduced 0.47%	87,253 $1.4 Million
Q2 2022 Aug 10, 2022	BUY	$7.96 - $16.64 $43,183 - $90,272	5,425 Added 6.6%	87,661 $1.21 Million
Q1 2022 May 12, 2022	BUY	$13.16 - $23.68 $245,605 - $441,939	18,663 Added 29.36%	82,236 $1.31 Million
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $314,428 - $526,288	14,611 Added 29.84%	63,573 $1.38 Million
Q3 2021 Nov 08, 2021	BUY	$27.42 - $48.97 $187,114 - $334,171	6,824 Added 16.19%	48,962 $1.46 Million
Q2 2021 Aug 11, 2021	BUY	$39.41 - $47.25 $419,243 - $502,645	10,638 Added 33.77%	42,138 $1.87 Million
Q1 2021 May 11, 2021	SELL	$43.34 - $65.91 $718,230 - $1.09 Million	-16,572 Reduced 34.47%	31,500 $1.4 Million
Q4 2020 Feb 11, 2021	SELL	$23.3 - $59.57 $193,692 - $495,205	-8,313 Reduced 14.74%	48,072 $2.64 Million
Q3 2020 Nov 09, 2020	BUY	$20.5 - $28.59 $99,240 - $138,404	4,841 Added 9.39%	56,385 $1.29 Million
Q2 2020 Aug 10, 2020	SELL	$13.32 - $22.61 $341,444 - $579,584	-25,634 Reduced 33.21%	51,544 $1.08 Million
Q1 2020 Apr 24, 2020	BUY	$9.71 - $25.11 $433,823 - $1.12 Million	44,678 Added 137.47%	77,178 $1.08 Million
Q4 2019 Feb 06, 2020	BUY	$11.07 - $24.23 $359,775 - $787,475	32,500 New	32,500 $740,000

Others Institutions Holding RCKT

# of Institutions

243

Shares Held

106M

Call Options Held

268K

Put Options Held

119K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $792M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Rocket Pharmaceuticals, Inc. Transaction History